As of 2024-12-14, the Fair Value of Aligos Therapeutics Inc (ALGS) is -107.18 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 33.11 USD, the upside of Aligos Therapeutics Inc is -423.70%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -52.26 | -108.54 | -128.33 | -96.05 | -87.68 | -94.57 |
| YoY growth | -275.16% | -107.69% | -18.23% | 25.15% | 8.72% | -73.44% |
| Market Cap (mil) | 118.86 |
| P/E | |
| Forward P/E |
| EPS | -21.44 |
| Avg earnings growth rate | -73.44% |
| TTM earnings | -76.95 |